INSIGHTS ON CLINICAL TRIAL PARTNERING

• How Do Site Payments Impact Clinical Trial Sustainability?

  Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,

• The Rise Of Targeted Modalities In Pharmaceutical Development

  Targeted modalities are pushing the boundaries of technology and therapeutic effectiveness. Their potential to transform patient care depends on leveraging the right expertise, technologies, and partnerships.

• What Sites Really Want: Insights From The 2024 Site Landscape Survey

  Take a closer look at the 2024 SCRS Site Landscape Survey—and what sites say they need most. Less friction. More follow-through. And partners who actually lighten the load.

• Global Trials Can't Afford To Overlook Africa

  Africa’s trial capacity is growing, but patient services remain the key to retention and reliable outcomes. Sponsors that act now can shape Africa into a true global trial hub.

• Stay Audit-Ready: Practical Compliance Insights For Research Sites

  3/26/2026

  Gain an auditors insight into common compliance gaps and learn practical ways to strengthen audit readiness in sIRB studies.

• Finding The Solution(s) That Meet The Needs Of Patients, Sites, And Sponsors

  12/4/2025

  Poor enrollment and retention often stem from patient burden and limited site access. Learn how leveraging diverse site networks and remote support can transform the clinical trial experience.

• FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study

  3/12/2026

  Adopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.

• Participant Payments: Navigating Modern Studies

  12/18/2024

  To address the challenges of disbursing clinical trial participant payments globally, sponsors need region-specific payment solutions that navigate local laws and banking systems.

• Optimizing Site Activation To Accelerate Clinical Trials

  6/5/2025

  Clinical trial site activation delays are a major bottleneck in drug development, hampering trial timelines and funding flows. To reverse this trend, site-focused solutions are being prioritized.